GRANDPHARMA (00512.HK) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Dec8

Farmiton’s Antidepressant Drug GPN01360 Successfully Completes Phase II Clinical Trials in China

10:08

Nov10

Farmito Pharmaceutical Obtains Ryaltris Market Approval in China

09:43

Huaxi Securities Upgrades Yuanda Medicine to 'Buy' Rating for the First Time

09:39

Nov1

YuanDa Pharmaceutical Launches Varenicline Tartrate Nasal Spray, A New Approach to Treating Dry Eye Syndrome

03:57

Oct27

Farapulse OC-01 Dry Eye Treatment Drug Launches Nationwide

09:15

Oct26

Farapulse Completes First Patient Enrollment in IIa Phase Clinical Trial for GPN00884 Eye Drops in China

10:29

Schedules & Filings

Schedules

Filings

Aug19

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 3.054 B, Net Income 584.51 M, EPS 0.1669

Apr28

Distribution Plan(CST)

Cash dividend 0.26 HKD

Apr15

Distribution Plan(CST)

Cash dividend 0.26 HKD

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More